Well no. As you probably know MSF is a charitable organisation without spending power, and since they've determined that resapp are resolving smartcough C issues, and the announcement states the MSF trial will impact MSF costs, they will suspend their field evaluation. Suspend.
- Forums
- ASX - By Stock
- RAP
- Ann: Update on Field Evaluation by Medecins Sans Frontieres
Ann: Update on Field Evaluation by Medecins Sans Frontieres, page-15
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online